Synthesis and antitussive evaluation of verticinone-cholic acid salt,a novel and potential cough therapeutic agent  

作　　者：Fang-zhou XU Chang CHEN Yong-hui ZHANG Han-li RUAN Hui-fang PI Pong ZHANG Ji-zhou WU 

机构地区：[1]Faculty of Pharmaceutical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China [2]Dempartment of Pharmacy, Peking University Shenzhen Hospital, Shenzhen 518036, China

出　　处：《Acta Pharmacologica Sinica》2007年第10期1591-1596,共6页中国药理学报（英文版）

基　　金：the Fund of the Key Project of the Rducation Ministry, China, 2006;the Fund of the International Cooperation Project of Science and Techno-logy;the Ministry of Science and Techno-logy, China (China and Korea, № 2006DFA33210);The present study has been applied fnr patent in China (application № 200610019027.0).

摘　　要：Aim： To seek a novel and potent antitussive drug based on Shedan-Chuanbei powder, a complex of traditional Chinese medicine preparation for cough therapy. Methods： Verticinone--cholic acid （Ver-CA） salt, a novel, salifying derivative of verticinone and cholic acid, both of which are the major bioactive components in Shedan-Chuanbei powder, was synthesized. We then evaluated the antitussive activity and the acute toxicity of the salt. Results： The new compound, with good solubility in water, has much more potent antitussive activity in comparison with the same dose of single verticinone and single cholic acid. The administration 3 mg/kg of Ver-CA could result in over 50% reduction of a citric acid-induced cough. Pretreatment with naloxone （0.8 mg/kg, ip） can only partially antagonize its antitussive effect. On the other hand, glybenclamide （3 mg/kg, ip）, an ATP-sensitive K^＋channel blocker, can also significantly reduce the antitussive effect of Ver-CA. A further acute toxicity study showed that the LD50 values of Ver-CA were 3 times that of verticinone. Conclusion： Based on the studies of pharmacology and acute toxicity, the salt has a synergic and attenuated toxicity compared with single verticinone and cholic acid. Moreover, the present study also suggests that VerCA, a potential novel antitussive agent, may exert its antitussive effect via both the peripheral （modulated by ATP-sensitive K^＋ channels） and central mechanisms （modulated by the opioid receptor）.Aim： To seek a novel and potent antitussive drug based on Shedan-Chuanbei powder, a complex of traditional Chinese medicine preparation for cough therapy. Methods： Verticinone--cholic acid （Ver-CA） salt, a novel, salifying derivative of verticinone and cholic acid, both of which are the major bioactive components in Shedan-Chuanbei powder, was synthesized. We then evaluated the antitussive activity and the acute toxicity of the salt. Results： The new compound, with good solubility in water, has much more potent antitussive activity in comparison with the same dose of single verticinone and single cholic acid. The administration 3 mg/kg of Ver-CA could result in over 50% reduction of a citric acid-induced cough. Pretreatment with naloxone （0.8 mg/kg, ip） can only partially antagonize its antitussive effect. On the other hand, glybenclamide （3 mg/kg, ip）, an ATP-sensitive K^＋channel blocker, can also significantly reduce the antitussive effect of Ver-CA. A further acute toxicity study showed that the LD50 values of Ver-CA were 3 times that of verticinone. Conclusion： Based on the studies of pharmacology and acute toxicity, the salt has a synergic and attenuated toxicity compared with single verticinone and cholic acid. Moreover, the present study also suggests that VerCA, a potential novel antitussive agent, may exert its antitussive effect via both the peripheral （modulated by ATP-sensitive K^＋ channels） and central mechanisms （modulated by the opioid receptor）.

关 键 词：verticinone-cholic acid salt Shedan-Chuan-bei powder  cholic acid verticinone antitussive effect ATP-sensitive K^＋ channels 

分 类 号：R98[医药卫生—药品]